Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0027947 (
neutropenia
)
17,527
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Ecthyma gangrenosum
is a skin manifestation of systemic sepsis commonly caused by Pseudomonas aeruginosa in patients with
neutropenia
or underlying immune deficiency. Although the usual outcome is poor, early recognition and appropriate systemic antibiotic treatment can lead to successful outcome. We report a case of a previously healthy lady with no apparent immune deficiency or
neutropenia
who had ecthyma gangrenosum of left lower limb in which the arterial line was placed.
...
PMID:Ecthyma gangrenosum of a single limb. 2201 15
Ecthyma gangrenosum
is the cutaneous manifestation of pseudomonas infection in patients with sepsis. A previously healthy 7-month-old girl who developed ecthyma gangrenosum without apparent inciting factors became neutropenic secondary to autoimmune
neutropenia
2 months after initial presentation. She was treated with appropriate surgical and medical intervention and was discharged in stable condition only to die suddenly 2 days after discharge.
...
PMID:Ecthyma gangrenosum and neutropenia in a previously healthy child. 2247 37
Ecthyma gangrenosum
(EG) is a cutaneous infection most commonly associated with Pseudomonas aeruginosa sepsis. EG generally occurs in immunocompromised hosts, such as patients with severe
neutropenia
. EG presents as erythematous, hemorrhagic, or necrotic macules or plaques, most commonly in the perineal or gluteal areas, but can occur elsewhere. EG is a dermatologic emergency in immunocompromised patients and should be included in the differential diagnosis when urologists are asked to evaluate perineal lesions. We describe the case of a highly immunocompromised infant with labial EG to highlight the importance of prompt clinical diagnosis and of multidisciplinary medical and surgical management.
...
PMID:Labial ecthyma gangrenosum in an immunocompromised infant with leukemia: heightening awareness for the urologist. 2304 Mar 28
Ecthyma gangrenosum
(EG) is often defined as a cutaneous manifestation of Pseudomonas aeruginosa septicaemia, typically secondary to
neutropenia
. There is increasing recognition that a broader definition is warranted, as numerous causative organisms and predisposing conditions have been reported. We describe two cases of EG that occurred without bacteraemia. In this atypical subset of cases, the skin is thought to represent the primary inoculation site from which haematogenous spread can occur. The first case occurred in the context of human immunodeficiency virus (HIV) infection, a rarely reported association. The evidence base guiding clinicians on management of EG is very limited, particularly in relation to patients with HIV, in whom recurrence risk may be higher than normal. Recurrent EG is described in our second case, in an individual with Good syndrome, a rare association of thymoma and immunodeficiency.
...
PMID:Ecthyma gangrenosum without bacteraemia: evidence in favour of a broader definition. 2823 2
Ecthyma gangrenosum
(EG) is a well-described skin manifestation of
Pseudomonas aeruginosa
septicemia in immunocompromised patients. However, it can be seen in association with other bacteria, viruses, and fungi. We report a case of a 54-year-old African American female with metastatic gastric adenocarcinoma and recent chemotherapy and
neutropenia
who developed EG-like lesions due to methicillin-susceptible
Staphylococcus aureus
. We also review the literature to evaluate all reported cases of
S aureus
-associated EG and their clinical presentation, diagnosis, and treatment.
...
PMID:Ecthyma gangrenosum secondary to methicillin-sensitive
Staphylococcus aureus
. 2849 17
Ecthyma gangrenosum
is a rare skin infection classically associated with Pseudomonas aeruginosa. We performed a retrospective study of all cases diagnosed with ecthyma gangrenosum from 2004-2010 in a university hospital in Mexico (8 cases, 5 female patients and 3 male patients, ages between 4 months and 2 years). The most common risk factor for ecthyma gangrenosum is
neutropenia
in immunocompromised patients. In previously healthy patients, immunological evaluation is important to rule out underlying immunodeficiency.
Ecthyma gangrenosum
in healthy patients has a high mortality rate and early diagnosis and aggressive antibiotic treatment is imperative as it can improve patients' prognosis.
...
PMID:Ecthyma gangrenosum: a report of eight cases. 2916 10
Ecthyma gangrenosum
(EG) is a severe potentially lethal cutaneous infection that progresses sequentially from maculopapular rash to haemorrhagic bulla and then to necrotic ulceration with surrounding erythema. It usually occurs in immunocompromised patients (aplasia secondary to chemotherapy, HIV infection,
neutropenia
or functional deficit of neutrophils, agammaglobulinemia). It rarely affects healthy people. Differential diagnosis includes leishmaniasis, pyoderma gangrenosum, eschars and papulonecrotic tuberculides. Blood cultures and/or local sample allow the isolation of P. aeruginosa, which is the causative germ. Treatment is based on suitable parenteral antibiotic therapy according to results of susceptibility tests (third-generation cephalosporins, fluoroquinolones). We here report the case of a 2-year old child with no particular past medical history presenting with multiple necrotic ulcers on the back with erythematous border evolving in a febrile context. Blood culture was negative. Laboratory tests showed sedimentation rate 30 mm, CRP 80mg/l. Bacteriological sampling of pus revealed pseudomonas aeruginosa. The diagnosis of ecthyma gangrenosum was made. The patient underwent parenteral third-generation cephalosporins. Complete patient recovery with healing occurred after 4 weeks.
...
PMID:[Ecthyma gangrenosum]. 3034 79
Ecthyma gangrenosum
is a cutaneous manifestation of severe systemic pseudomonas infection and is commonly associated with bacteremia. It is common in immunocompromised patients with underlying
neutropenia
or leukopenia. We report a patient with heart transplant who developed a single lesion of ecthyma gangrenosum in the absence of bacteremia with a review of reported cases in solid organ transplant patients.
...
PMID:Ecthyma gangrenosum without bacteremia in a 54-year-old woman with heart transplant. 3239 52
<< Previous
1
2